ZyVersa Therapeutics, Inc. - Common Stock (ZVSA)

ZyVersa Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for a variety of medical conditions, particularly those associated with inflammation and metabolic diseases

The company aims to address unmet medical needs through its research and development of novel drug candidates that target key biological pathways. By leveraging its proprietary technologies, ZyVersa is engaged in advancing therapies that not only have the potential to improve patient outcomes but also enhance the overall quality of life for individuals suffering from chronic ailments.